Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 106.23%6.88M | 268.26%13.87M | 87.32%-8.24M | -47.57%-17.62M | 174.67%18.87M | -3.65%-110.44M | 34.54%-8.24M | -48.74%-65M | 59.75%-11.94M | -22.62%-25.27M |
Net income from continuing operations | 17.21%-92.26M | -36.39%-13.65M | 90.56%-2.1M | -2.92%-43.59M | 10.61%-32.92M | 26.16%-111.44M | 70.93%-10.01M | 49.42%-22.25M | 14.18%-42.36M | -59.06%-36.83M |
Operating gains losses | 236.55%16.75M | --13.85M | ---9.89M | --981K | --11.81M | -408,866.67%-12.26M | ---- | ---- | ---- | ---- |
Depreciation and amortization | 5.88%10.03M | 4.12%2.53M | 9.44%2.56M | 9.18%2.58M | 0.81%2.36M | 29.82%9.47M | 23.51%2.43M | 33.09%2.34M | 31.28%2.36M | 32.09%2.34M |
Deferred tax | 41.66%-899K | 152.11%382K | -3.10%-299K | 39.20%-532K | -226.05%-450K | -41.51%-1.54M | -259.35%-733K | -17.41%-290K | -282.10%-875K | 133.27%357K |
Other non cash items | 32.66%589K | 47.06%150K | 25.21%149K | -1.96%150K | 100.00%140K | 932.56%444K | --102K | --119K | --153K | --70K |
Change In working capital | 166.70%26.41M | -73.79%434K | 84.81%-8.54M | -59.33%7.05M | 1,253.34%27.46M | -1,866.82%-39.59M | -77.04%1.66M | -328.59%-56.2M | 93.05%17.33M | 53.23%-2.38M |
-Change in receivables | -1,417.83%-28.35M | -82.01%-59.21M | -412.44%-6.26M | -126.66%-2.95M | 127.50%40.06M | 95.07%-1.87M | -12.93%-32.53M | 109.42%2M | 197.47%11.05M | 109.23%17.61M |
-Change in prepaid assets | 130.23%16.55M | -37.19%4.27M | 103.10%1.76M | 229.18%12.77M | 74.50%-2.25M | -2,601.18%-54.75M | 44.85%6.8M | -3,977.11%-56.63M | 321.03%3.88M | -145.96%-8.8M |
-Change in payables and accrued expense | 16.11%-3.82M | -40.15%1.66M | -152.02%-4.55M | -54.77%2.59M | 68.74%-3.52M | -238.20%-4.55M | -47.73%2.78M | -324.47%-1.81M | 250.21%5.73M | -152.17%-11.25M |
-Change in other current liabilities | -30.34%-1.48M | -325.67%-2.01M | 113.39%414K | -253.29%-1.82M | 22.88%1.94M | -329.55%-1.13M | 649.58%892K | -25,866.67%-3.09M | 1.53%-516K | 1,126.36%1.58M |
-Change in other working capital | 91.54%43.51M | 134.95%55.73M | -96.85%105K | -25.88%-3.54M | -477.07%-8.78M | -34.93%22.71M | -8.40%23.72M | -61.74%3.33M | -147.64%-2.81M | 72.81%-1.52M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 106.23%6.88M | 268.26%13.87M | 87.32%-8.24M | -47.57%-17.62M | 174.67%18.87M | -3.65%-110.44M | 34.54%-8.24M | -48.74%-65M | 59.75%-11.94M | -22.62%-25.27M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -223.78%-35.39M | -103.95%-1.1M | -148.26%-12.67M | -122.79%-29.09M | 160.56%7.46M | 178.55%28.59M | 375.06%27.72M | 32.74%26.24M | -756.13%-13.06M | -686.76%-12.32M |
Net PPE purchase and sale | 60.59%-3.8M | 62.40%-511K | 24.95%-355K | 78.31%-734K | 50.28%-2.2M | -5.96%-9.64M | 57.98%-1.36M | 59.78%-473K | -161.31%-3.38M | -30.41%-4.42M |
Net investment purchase and sale | -182.64%-31.59M | -102.01%-585K | -146.08%-12.31M | -193.16%-28.35M | 222.32%9.66M | 97.46%38.23M | 524.90%29.08M | 27.55%26.71M | -4,105.22%-9.67M | -243.83%-7.9M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -223.78%-35.39M | -103.95%-1.1M | -148.26%-12.67M | -122.79%-29.09M | 160.56%7.46M | 178.55%28.59M | 375.06%27.72M | 32.74%26.24M | -756.13%-13.06M | -686.76%-12.32M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -100.33%-258K | 355.60%8.24M | 45.39%-1.8M | 0.49%-2.45M | -104.82%-4.25M | -44.59%79.17M | -102.74%-3.22M | -1,984.57%-3.3M | -492.65%-2.46M | 261.19%88.14M |
Net issuance payments of debt | -50.53%43.75M | -166.52%-2.5M | -33.26%-1.25M | -33.40%-1.25M | -46.58%48.75M | -25.92%88.44M | -100.79%-938K | ---938K | ---937K | --91.25M |
Net common stock issuance | ---50.02M | --0 | --0 | --0 | ---50.02M | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | 1,823.01%14.46M | 15,629.55%13.84M | 5.71%111K | -61.92%163K | 163.36%345K | -97.04%752K | -61.23%88K | -40.00%105K | -31.63%428K | -99.46%131K |
Net other financing activities | 15.70%-8.45M | -30.80%-3.1M | 73.14%-662K | 30.27%-1.36M | -2.72%-3.33M | -416.70%-10.02M | ---2.37M | ---2.47M | ---1.95M | ---3.24M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -100.33%-258K | 355.60%8.24M | 45.39%-1.8M | 0.49%-2.45M | -104.82%-4.25M | -44.59%79.17M | -102.74%-3.22M | -1,984.57%-3.3M | -492.65%-2.46M | 261.19%88.14M |
Net cash flow | ||||||||||
Beginning cash position | -0.68%149.35M | -24.14%99.19M | -30.50%120.79M | -15.35%170.11M | -0.68%149.35M | 44.65%150.38M | 142.80%130.76M | 119.73%173.8M | 82.86%200.96M | 44.65%150.38M |
Current changes in cash | -970.71%-28.77M | 29.28%21.01M | 46.00%-22.71M | -79.04%-49.15M | -56.34%22.08M | -105.77%-2.69M | -82.89%16.25M | -77.04%-42.05M | 10.16%-27.45M | 757.15%50.56M |
Effect of exchange rate changes | -222.45%-2.03M | -170.80%-1.65M | 212.96%1.12M | -158.50%-172K | -8,893.33%-1.32M | 1,142.14%1.66M | 52.18%2.34M | 33.65%-988K | 220.00%294K | -62.50%15K |
End cash Position | -20.62%118.55M | -20.62%118.55M | -24.14%99.19M | -30.50%120.79M | -15.35%170.11M | -0.68%149.35M | -0.68%149.35M | 142.80%130.76M | 119.73%173.8M | 82.86%200.96M |
Free cash flow | 102.56%3.08M | 239.12%13.36M | 86.87%-8.6M | -19.76%-18.35M | 156.15%16.67M | -3.83%-120.08M | 39.33%-9.6M | -45.90%-65.47M | 50.50%-15.32M | -23.72%-29.69M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |